Avalon GloboCare Aims to Revolutionize Cell Therapy Market with a Faster, Safer CAR-T TreatmentBenzinga • 09/30/21
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Avalon GloboCare Corp. - AVCOPRNewsWire • 07/17/21
Avalon GloboCare says its planned acquisition target SenlangBio starts first-in-human clinical trial for recurrent brain cancerProactive Investors • 07/01/21
Avalon GloboCare Announces its Planned Acquisition Target, SenlangBio, has Initiated First-In-Human Clinical Trial in Recurrent Brain CancerGlobeNewsWire • 07/01/21
Avalon GloboCare says SenlangBio will enhance its capabilities in cell and gene therapyProactive Investors • 06/28/21
Avalon GloboCare CEO Provides Letter to Update Shareholders About Acquisition of SenlangBioGlobeNewsWire • 06/28/21
INVESTIGATION ALERT: Halper Sadeh LLP Investigates FBNC, AVCO, XEC, CLDR, SBBP; Shareholders are Encouraged to Contact the FirmPRNewsWire • 06/16/21
Avalon Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Avalon GloboCare Corp. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – AVCOBusiness Wire • 06/14/21
Avalon GloboCare Adds Cell Therapy-Based Candidates For Cancer With SenlangBio Acquisition: HighlightsBenzinga • 06/14/21
Avalon GloboCare inks definitive agreement to acquire Chinese cell therapy company Senlang BiotechnologyProactive Investors • 06/14/21
Avalon GloboCare Announces Execution of Purchase Agreement for Acquisition of SenlangBio in All Stock TransactionGlobeNewsWire • 06/14/21
Avalon GloboCare to Present at the Noble Capital Markets Investor Forum During the 16th Annual World Stem Cell Summit on June 17, 2021GlobeNewsWire • 06/11/21
Avalon GloboCare says CEO to present S-layer nanotechnology, QTY code platforms at 2021 World Stem Cell SummitProactive Investors • 06/08/21
Avalon GloboCare To Present Its S-Layer and QTY Code Breakthrough Technology Platforms at The Prestigious Annual World Stem Cell SummitGlobeNewsWire • 06/08/21
Avalon GloboCare is seeking to tap the power of cells to fight cancer and coronavirusProactive Investors • 04/20/21
Avalon GloboCare to partner with University of Pittsburgh Medical Center Hillman Cancer Center to develop therapies using FLASH-CAR techProactive Investors • 03/29/21
Avalon GloboCare Announces Collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center to Advance Clinical Development of Cellular Immunotherapies Using the FLASH-CAR™ PlatformGlobeNewsWire • 03/29/21
Avalon GloboCare expands its MIT co-development research program to fight cancer spreadProactive Investors • 03/22/21
Avalon GloboCare Expands Co-Development Program with MIT to Combat Cancer MetastasisGlobeNewsWire • 03/22/21
Avalon GloboCare seeking to tap the power of cells to fight cancer and coronavirusProactive Investors • 03/15/21
Avalon GloboCare and University of Natural Resources and Life Sciences (BOKU) Expand Partnership and Accelerate Development of S-Layer Based Vaccines and Cellular TherapeuticsGlobeNewsWire • 12/30/20
Avalon GloboCare and Adial Pharmaceuticals Announce Strategic Collaboration for Global Distribution of COVID-19 Point-of-Care Antibody Rapid Test DevicesGlobeNewsWire • 10/22/20
Avalon GloboCare Provides Clinical Updates on Its CAR-T Immuno-Oncology and Allogeneic Mesenchymal Stromal Cell (MSC) Therapy Programs Following Successful Completion of Phase I AVA-001 Clinical TrialGlobeNewsWire • 10/01/20
Avalon GloboCare CEO to Participate in Virtual Panel: “New Approaches to COVID-19: Hidden Breakthroughs,” on Thursday, September 10thGlobeNewsWire • 09/03/20